294,654 $3,677,648
Depreciation and amortization 419,903 258,021
Stock based compensation 47,624 --
Changes in assets and liabilities:
Trade accounts receivable (1,224,072) (4,992,389)
Other receivables (6,209) (46,549)
Advances to suppliers (1,037,525) 1,211,004
Inventory (1,604,046) (49,800)
Deferred tax assets (72,339) (122,965)
Trade accounts payable 318,952 1,174,251
Accrued expenses (36,265) (7,723)
Accrued taxes payable 155,402 (15,659)
Other payables 2,043 2,004
Advances from customers (134,791) 29,292
Net Cash Provided by Operating Activities 1,123,331 1,117,135
Cash Flows from Investing Activities:
Advances for purchases of property
and equipment and intangible assets (1,291,216) (2,376,453)
Purchase of property and equipment (58,272) (523,476)
Purchase of intangible assets (1,207,541) --
Net Cash Used in Investing Activities (2,557,029) (2,899,929)
Cash Flows from Financing Activity:
Proceeds from exercise of warrants 2,583,000 --
Net Cash Provided by Financing Activity 2,583,000 --
Effect of Exchange Rate Changes on Cash 527 7,527
Net Increase (Decrease) in Cash 1,149,829 (1,775,267)
Cash and Cash Equivalents at
Beginning of Period 3,634,753 6,927,149
Cash and Cash Equivalents at End of
Period
'/>"/>SOURCE China Pharma Holdings, Inc. Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 Related biology technology :1.
China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results2.
China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results3.
China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day4.
China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.5.
China Technology Announces New Chief Financial Officer6.
China Medical Technologies Reports First Quarter Financial Results7.
China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference8.
China Technology Announces Entry to the Solar Energy Sector9.
China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products10.
Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association11.
China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch